Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3411 of 6351
-
Wild blueberries put to the test for Parkinson's motor symptoms
Symptom relief CompletedThe purpose of this study involved investigating the effects of daily ingested wild blueberry drink (22.5 g wild blueberry powder added to pineapple juice) for 8 weeks on movement of people diagnosed with Parkinson's disease. Specifically, the investigators questioned: * Do the …
Phase 1 • Sponsor: Louisiana State University, Baton Rouge • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis phase I trial studies the side effects and best dose of cord blood-derived expanded allogeneic natural killer cells (donor natural killer \[NK\] cells) and how well they work when given together with cyclophosphamide and etoposide in treating children and young adults with s…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could your own blood heal a stubborn eye ulcer?
Disease control Recruiting nowPersistent epithelial defects (PED) are corneal ulcers that do not heal within the first two weeks of treatment with artificial tears or ocular lubricant ointment. It is believed that this condition is the result of the loss of certain substances normally present in the tears tha…
Sponsor: Universidad Autonoma de Nuevo Leon • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental CAR T-Cell therapy targets tough lymphoma
Disease control Stopped earlyThe purpose of this study is to test the safety and efficacy of AUTO4 a chimeric antigen receptor (CAR) T cell treatment targeting TRBC1 in patients with relapsed or refractory TRBC1 positive selected T-Non-Hodgkin Lymphoma (NHL).
Phase 1/2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Quick swab test could prevent newborn sepsis
Diagnosis CompletedThe purpose of the protocol is to validate a novel point of care multiplex system to detect and characterize microorganisms responsible for neonatal sepsis, as well as biomarkers of infection, from a simple vaginal sample, in order to improve the prevention of perinatal bacterial…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New drug cocktail aims to tackle childhood cancers that Won't quit
Disease control CompletedThis study is being conducted in order to determine the safety, dose-limiting toxicities, and maximum tolerated dose of cabozantinib in combination with 13-cis-retinoic acid in patients with relapsed or refractory solid tumors including tumors of the central nervous system (CNS)
Phase 1 • Sponsor: Peter Zage • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Kidney cancer drug combo trial halted early – what we know
Disease control Stopped earlyThis phase I trial studies the side effects and best dose of aldesleukin when given together with pembrolizumab in treating patients with kidney cancer that has spread to other parts of the body. Aldesleukin may stimulate white blood cells to kill kidney cancer cells. Immunothera…
Phase 1 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New shoulder implant under scrutiny: will it hold up?
Disease control OngoingThis study is a multicenter, prospective, non-randomized, non-controlled, dual cohort post market surveillance study. The primary objective of this study is to confirm the safety and performance of the Comprehensive Reverse Shoulder System when used with the Comprehensive Porous …
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New stomach-shrinking procedure helps with weight loss
Disease control CompletedThis will be a prospective, registry study of an investigational procedure for at least 12 standard of care visits up to 1 year after subject consents for study. Subjects will be enrolled between 8/1/2018 and 8/1/2023. Subjects will undergo a clinically indicated endoscopic proce…
Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Experimental drug targets rare blood cancer in tiny trial
Disease control CompletedThis research study is studying a drug as a possible treatment for BPDCN. The intervention involved in this study is: Venetoclax
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Coaching program aims to empower parents of kids with developmental delays
Symptom relief CompletedChildren with, or at elevated risk for, brain-based developmental disabilities can experience lifelong consequences and challenges throughout their development. In particular, preschool years (3-6 years of age) can be stressful as families wait to get services and care for their …
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can a diabetes drug help PAH patients walk farther?
Symptom relief CompletedThe primary objective of this study is to determine the impact of two interventions against insulin resistance on the composite endpoint of 10% improvement in baseline six minute walk distance or improvement in World Health Organization (WHO) functional class in humans with pulmo…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a common Alzheimer's drug clear lupus brain fog?
Symptom relief CompletedA phenome-wide association study (PheWAS) identified an association between a variant in the human gene for the N2A subunit of the N-methyl-D-aspartate (NMDA) receptor, GRIN2A, and Systemic Lupus Erythematosus (SLE). A single nucleotide polymorphism (SNP) in this gene encodes for…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Magnetic pulses may help brain tumor patients regain movement after surgery
Symptom relief OngoingThis trial studies how well navigated repetitive transcranial magnetic stimulation works in improving motor rehabilitation in participants with brain tumors. Navigated repetitive transcranial magnetic stimulation may help improve patients' lost motor function after surgery.
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Wrist access may ease liver cancer treatment
Disease control CompletedThis study is a prospective, observational clinical trial designed to evaluate the feasibility, safety, and effectiveness of performing transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) using a transradial arterial approach. Traditionally, TACE procedures …
Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 26, 2026 14:47 UTC
-
New test may improve preterm birth prediction
Diagnosis CompletedThe primary purpose of the protocol is to compare the diagnostic accuracy in terms of positive and negative predictive values of Premaquick © (combined detection of IL-6 / IGFBP-1 total / IGFBP-1 native) and Quikcheck fFN ™ (fibronectin detection) tests for prediction of spontane…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Could a common eye drop gel speed up wound healing?
Symptom relief CompletedThe use of topical beta-blockers, such as 0.25% timolol, in promoting wound healing is currently emerging in the academic literature. The investigators will enroll 114 patients who have their skin cancer surgically removed resulting in open surgical wounds less or equal to 1.5 cm…
Phase 2/3 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Text and video counseling shows promise for HIV youth
Disease control CompletedYouth To Text or Telehealth for Engagement in HIV Care (Y2TEC) is a randomized control pilot to assess the feasibility and acceptability of delivering a targeted problem-solving intervention to youth ages 18-29 living with HIV (YLWH) for improving HIV care engagement, mental heal…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
Can genetic screening help prevent cancer in underserved communities?
Knowledge-focused CompletedThe CHARM (Cancer Health Assessment Reaching Many) study will assess the utility of clinical exome sequencing and how it affects care in diverse populations. The study population includes adults at risk for hereditary cancer syndromes. The primary objective is to implement a her…
Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:54 UTC
-
Teaching doctors to talk about pain: a new approach to safer opioid prescribing
Knowledge-focused CompletedThe overall goal of this protocol is to pilot test a clinician training intervention that uses standardized patients (trained actors playing patient roles) as instructors who impart communication skills to primary care clinicians. This project will conduct a pilot clinical trial …
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC